Statistical Consulting

Optimize your clinical development—from study design to submission and beyond—with our innovative statistical strategies

Reduce costs and timeline of your clinical trial

Our dedicated, in-house experts use the most innovative methods to support the development of study designs across a wide range of therapeutic areas and phases for both medical devices and drugs.

We’ll work closely with you to support regulatory interactions and oversight implementation.

No matter how complex your project, get tailored, comprehensive support, including:
  • Statistical strategy for clinical development plans
  • Study design and protocol development
  • Power and Sample size calculation
  • Implementation of complex statistical methodologies
  • Support for interim analyses
  • Support for Data Monitoring Committees / Data Safety Monitoring Boards
  • Support for regulatory interactions

Why choose Alira Health?

Alira Health biometrics team has provided expert statistical guidance for over 500 projects. As our partner, you’ll benefit from:

  • Working with the subject matter experts and statistical consultants with over 20 years of clinical development experience
  • Strategic input on clinical development plans and protocols
  • Strong know-how in the latest statistical methods
  • Direct access to an in-house team of regulatory experts

Related News

Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Events August 10, 2022
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Publications August 2, 2022
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
The last two years have brought forward tremendous advances in the development of prophylactic and therapeutic approaches for the treatment of SARS-CoV-2 infections.
Clinical CMC Vaccines
Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.